UK markets closed

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.36-0.30 (-3.46%)
At close: 04:00PM EDT
8.42 +0.06 (+0.72%)
After hours: 07:44PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
88,398
53,641
96,449
65,082
-
Other short-term investments
183,463
355,948
290,610
219,359
-
Total cash
271,861
409,589
387,059
284,441
-
Net receivables
25,807
8,458
0
-
-
Inventory
13,134
7,514
0
-
-
Other current assets
8,208
6,257
8,025
-
-
Total current assets
330,431
437,406
402,773
292,826
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,824
5,755
5,833
5,443
-
Accumulated depreciation
-1,924
-1,153
-532
-78
-
Net property, plant and equipment
3,900
4,602
5,301
5,365
-
Other long-term assets
596
78
78
78
-
Total non-current assets
10,934
11,868
5,379
5,443
-
Total assets
341,365
449,274
408,152
298,269
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
11,992
8,827
7,353
7,140
-
Accrued liabilities
19,069
14,323
16,410
11,028
-
Total current liabilities
46,668
37,807
33,326
22,602
-
Non-current liabilities
Long-term debt
201,799
197,769
72,350
-
-
Other long-term liabilities
849
-
25
82
184
Total non-current liabilities
206,030
201,886
77,149
5,046
-
Total liabilities
252,698
239,693
110,475
27,648
-
Stockholders' equity
Common stock
9
6
5
4
-
Retained earnings
-981,904
-719,764
-408,306
-201,950
-
Accumulated other comprehensive income
4
-1,086
-255
-2
-
Total stockholders' equity
88,667
209,581
297,677
270,621
-
Total liabilities and stockholders' equity
341,365
449,274
408,152
298,269
-